The most important number in Third Avenue’s GLP-1 offer is not necessarily the largest one. A medication price advertised as $49 or $68 per month sits beside a $199 annual membership after a seven-day trial. Meanwhile, enrollment language introduces a 25-day billing interval, and product pages display additional prices without explaining their conditions. For someone budgeting recurring care, those details matter more than the simplicity of the headline.
This documentary review examines Third Avenue’s public materials consulted October 19, 2026, with particular attention to the first payment, recurring charges and what happens when an order becomes nonrefundable. Third Avenue markets access to compounded injectable semaglutide and tirzepatide, but its terms assign clinical care and dispensing to separate organizations. The offering has useful documented features, including online intake and ongoing support, alongside pricing and service discrepancies that deserve written clarification before payment.
At a glance
- Medication and membership are separate
- Product pages describe compounded injectable semaglutide at $49/month and tirzepatide at $68/month, each plus membership at $199/year after a seven-day trial.
- Billing interval is unresolved
- Enrollment materials use monthly language alongside 25-day billing language. The documented tirzepatide wording explicitly says $68 every 25 days.Sources: [9]
- Payment precedes clinical approval
- Third Avenue collects payment when the order is placed. It promises a full refund if the clinician does not approve treatment and no prescription is issued.Sources: [5]
- The platform is not the clinical provider
- Third Ave LLC operates the platform; the terms assign healthcare to MDI Medical Group PC and applicable affiliates, and dispensing to independent pharmacies.Sources: [10]
Start with the charge that actually reaches your card
Third Avenue describes its initial assessment as free and entirely online, with questions about health history, lifestyle and goals. That does not mean the purchase waits for a prescribing decision. The homepage says payment is collected when an order is placed, before clinical review. The seven-day membership trial also starts at checkout, so the financial timeline begins before the clinical process has necessarily reached its conclusion.
During that trial, the customer pays for medication; only the membership charge is deferred. The product pages say membership continues at $199 per year unless canceled before the trial ends. This is an annual membership charge, not a monthly membership price. Third Avenue promises a full refund when a provider declines treatment and no prescription is issued, but that defined outcome should not be confused with a general satisfaction guarantee.
Leaving the intake unfinished is particularly consequential. The refund policy says an incomplete intake leaves the request pending and the payment applied to it; inactivity does not automatically cancel the order or trigger a refund. Before paying, establish when review is expected and how to cancel a pending request. Our explanation of why a first payment can differ from the advertised price provides a useful framework for separating checkout charges from later obligations.
The medication prices need a written billing schedule
The semaglutide product page describes compounded semaglutide at $49 per month for medication, at the same price at any dose. The tirzepatide page similarly describes compounded tirzepatide at $68 per month at any dose. Both require the separate membership after its trial. The program page identifies these offerings as prescription injections. Those details establish an advertised medication-and-membership structure, but they do not resolve the amount or timing of every transaction.
The product cards also display $98 per month for semaglutide and $135 per month for tirzepatide alongside the lower figures. The supplied materials do not explain a qualifying group, promotional duration or other conditions that reconcile those amounts. Enrollment language adds another problem: it describes monthly subscriptions while also using 25-day billing language, including an explicit $68-every-25-days statement for tirzepatide. Neither a calendar month nor a four-week period means 25 days.
Ask for the selected product, medication charge, next charge date, subsequent interval and membership renewal date in one written quote. The materials do not establish the exact supply quantity per shipment, so a billing interval should not be treated as proof of how much medication arrives. Our guide to monthly, four-week and prepaid billing explains why matching the charge schedule to the supply schedule matters more than comparing monthly-looking labels.
| Cost item | Documented language | Question before payment |
|---|---|---|
| Compounded semaglutide injection | $49/month medication; $98/month also displayed | Which price applies to this order and later renewals? |
| Compounded tirzepatide injection | $68/month medication; $135/month also displayed | What conditions explain the alternative price? |
| Medication renewal | Monthly wording alongside 25-day billing language | What exact date and interval will the card be charged? |
| Membership | Seven-day trial, then $199/year | When does the annual charge occur, and how is it canceled? |
| Delivery | Free standard shipping and free overnight refill claims | Which service applies to the selected order? |
What the membership appears to buy
Third Avenue describes membership as paying for care beyond the medication itself: a team patients can message at any time, ongoing check-ins, clinician-directed adjustments, member refill pricing and free overnight shipping. The product page also says the plan covers required supplies, delivery and continuing clinical oversight. These are meaningful advertised inclusions, although the documents do not neatly allocate every service between the medication payment and the annual membership payment.
The GLP-1 program additionally describes nutrition support, strength-training guidance, progress tracking and help managing gastrointestinal symptoms. These are descriptions of available support, not independently established outcomes. Product pages mention scheduled physician follow-ups and secure messaging, but do not specify a fixed appointment frequency or guaranteed response time. A customer should therefore ask what proactive contact is scheduled, rather than assuming that access to messaging means regular appointments automatically occur.
Potential testing expenses remain another budgeting gap. The terms allow a clinician to require diagnostic testing, synchronous video communication, an in-person examination or further information before prescribing or continuing treatment. The supplied documents do not define a mandatory laboratory panel, testing frequency or whether those costs are included. A useful inclusion check separates supplies and shipping from testing and outside examinations; our guide to what a GLP-1 program price includes expands that distinction.
Who is responsible for the paid service
The homepage presents Third Avenue as a telehealth and pharmacy platform coordinating consultation, prescribing and fulfillment in one place. Its contract draws a sharper organizational boundary. The operator is Third Ave LLC, a Delaware limited liability company doing business as Third Avenue. The terms expressly say Third Avenue is not a healthcare provider or pharmacy and does not make diagnosis, treatment, prescribing, medical-necessity or dispensing decisions.
Healthcare services are assigned to MDI Medical Group PC and, where applicable, affiliated professional entities. Independent dispensing pharmacies fulfill prescriptions, and the terms do not guarantee a particular pharmacy for every order. The product page says the exact formulation and dispensing pharmacy depend on clinical review, the patient’s state and fulfillment availability. The consulted materials do not name those pharmacies or establish individual clinician credentials or pharmacy-license verification.
That separation matters when a charge or service problem needs an owner. Administrative billing questions go to the platform; prescribing decisions belong to the medical professionals; formulation and dispensing questions may require the pharmacy. The privacy policy similarly distinguishes clinical records maintained by the medical group and clinicians from platform business information. Where available and legally permitted, patients may request another pharmacy, but the terms warn that price, formulation, shipping, availability and program services can differ.
Cancellation and refunds follow different clocks
Enrollment materials say medication subscriptions renew automatically and either charge can be canceled by emailing support@thirdavenue.com. However, stopping a future subscription charge is different from recovering money for a current order. For an initial order, or an order requiring a new prescription, the refund policy makes the order final once a licensed healthcare provider approves treatment and issues the prescription, subject to policy exceptions—even before pharmacy transmission, dispensing or shipping.
Refills under an existing prescription have a different boundary. They become final when submitted to or accepted for processing by the dispensing pharmacy. If a renewal has been charged but is canceled before submission for pharmacy processing, the policy says that renewal charge will be refunded. Consequently, the decisive question is not simply whether the box has shipped; it is which clinical or pharmacy-processing step the order has reached.
Ordinary prescription returns are not accepted after products leave the pharmacy. The consulted documents also do not establish a prorated refund entitlement for an annual membership already charged. When a refund is approved, Third Avenue generally initiates it within five to ten business days after its determination; the financial institution may take longer to post it. Our guide to cancellation and refund boundaries helps distinguish future billing, order finality and the eventual return of funds.
Shipping promises and problem-reporting windows do not align
Third Avenue’s homepage distinguishes processing from arrival: orders are typically processed within 24–48 hours after prescription approval, while most arrive within three to five business days depending on location. Tracking is emailed once the package is on its way. Separately, membership advertising promises free overnight shipping on every refill, with cold shipping and plain packaging. Enrollment materials instead describe free, discreet standard shipping. These statements do not establish one uniform service level.
The reporting deadline for a problematic delivery is also inconsistent. The homepage asks customers to contact support as soon as possible and within seven days for damaged, defective or incorrect orders. The refund policy requires immediate reporting and, absent extraordinary circumstances, no later than 48 hours after confirmed delivery for damaged, defective, incorrect, missing or potentially transit-compromised products. Obtain clarification beforehand rather than relying on the longer homepage window after a problem occurs.
Refrigeration concerns require more than a billing inquiry. FDA advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. This is general FDA guidance, not a finding about Third Avenue deliveries. Confirm the pharmacy contact and delivery-handling instructions before shipment, and remember that a promised shipping method, dispatch estimate and arrival estimate describe different stages of the order.
Self-pay access still depends on location and clinical review
Third Avenue’s terms make the service cash-pay. The company does not submit claims to commercial insurance, Medicare, Medicaid or TRICARE for purchases through the platform. It also does not guarantee reimbursement through insurance, an HSA, an FSA or another benefit arrangement. This describes its payment model; it is not a documented blanket exclusion of people who have those forms of coverage. Budgeting should not assume reimbursement will reduce the quoted charge.
The homepage advertises telehealth for eligible patients physically located in all 50 states, while explicitly warning that not every treatment or medication is available in every state. Availability can depend on clinician licensure, pharmacy coverage, applicable law, product availability and individual eligibility. The terms require customers to be at least 18 or the age of majority in their jurisdiction if higher. National platform access therefore does not guarantee access to a particular compounded preparation.
The program says a licensed clinician reviews medical history and goals and does not rely on BMI alone. The semaglutide product page says treatment is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2 and leaves assessment of suitability to the clinician. The program also advertises review and support for people already prescribed a GLP-1 elsewhere. Neither statement guarantees a prescription, a transfer or acceptance of an existing treatment plan. Because the clinical review can require additional information or examinations, prospective patients should distinguish permission to start the online process from approval to receive medication.
Judge the price against a documented product and reachable support
The compounded status is material to understanding what the advertised price buys. Third Avenue’s enrollment page states that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, nor does it validate a particular preparation.
The supplied documentation does not establish each preparation’s complete composition, concentration, ingredient manufacturer or documented batch testing. It also does not establish outcomes for Third Avenue’s compounded products. Consequently, the lower advertised price cannot by itself answer questions about product suitability or expected results. Before purchasing, request the exact prescribed formulation and dispensing pharmacy rather than treating the ingredient name as a complete product description.
For practical support, the contact page lists support@thirdavenue.com and 302-428-9872, with care-team hours Monday through Friday, 8 a.m. to 8 p.m. Eastern. Messaging at any time is not a promise of immediate clinical response. The supplied materials do not establish guaranteed review times, message-response times or Spanish-language clinical care. Those service details belong in the cost conversation because an annual support charge is easier to evaluate when access and responsibilities are concrete.
Questions & answers
Is Third Avenue’s seven-day trial free medication?
No. The trial applies to membership only, begins at checkout and does not remove the medication charge. The product pages say membership becomes $199 per year unless canceled before the trial ends. Payment for the order is collected before clinical review. Ask for both the medication transaction and the membership charge date before submitting payment.
Will I definitely pay $49 or $68 each calendar month?
The documents do not establish that consistently. Product pages describe those medication prices as monthly, but enrollment materials introduce 25-day billing language. The pages also display $98 and $135 alternatives without resolving their conditions. Request the actual selected price, renewal dates and medication quantity in writing; the advertised monthly label is not enough to establish the payment schedule.
Can I cancel before shipment and automatically get my money back?
Not necessarily. An initial order or one requiring a new prescription generally becomes final when treatment is approved and the prescription is issued, subject to policy exceptions. A refill under an existing prescription becomes final at pharmacy-processing submission or acceptance. Cancellation before shipment may therefore be too late for a refund, even though future subscription charges can be stopped.
Does membership guarantee overnight delivery?
Membership advertising promises free overnight shipping on every refill, but enrollment materials describe free standard shipping. The homepage separately estimates processing and arrival times. These statements need reconciliation for the specific order. Ask which shipping service applies, whether it differs for the first order and refills, and when processing begins; overnight shipping language does not itself guarantee next-day arrival after checkout.
Can Third Avenue bill my insurance or guarantee HSA reimbursement?
No such arrangement is documented. Its terms say purchases are cash-pay and that it does not submit claims to commercial plans or government programs, including Medicare, Medicaid and TRICARE. It also makes no guarantee of insurance, HSA or FSA reimbursement. Confirm any potential benefit directly with the relevant plan or administrator rather than treating reimbursement as part of Third Avenue’s advertised price.
Who should I contact about a damaged or incorrect delivery?
The refund policy directs reports to support@thirdavenue.com immediately and generally within 48 hours of confirmed delivery, despite the homepage’s longer seven-day wording. The published phone number is 302-428-9872. For an injectable product arriving warm or inadequately refrigerated, FDA advises not using it and contacting the provider or dispensing pharmacy. Obtain the pharmacy’s contact information before a delivery problem arises.
Our assessment
Third Avenue documents a recognizable service structure: compounded prescription injections, a separate annual membership, online assessment, ongoing support, included supplies and delivery, and a defined refund pathway when treatment is declined without a prescription. Its terms also usefully distinguish the administrative platform from the medical group and dispensing pharmacies. The weakness for a cost-conscious reader is that the published pages do not form one consistent purchase agreement. Monthly versus 25-day billing, unexplained alternative prices, standard versus overnight shipping and conflicting delivery-report deadlines all affect the practical value of the offer. Before paying, obtain a written quote identifying the formulation, pharmacy, charge dates, supply quantity, included follow-up and applicable cancellation boundaries. The advertised medication prices are a starting point for that inquiry—not a complete, reliably documented ongoing budget.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Third Avenue — pages/contact ↗
- Third Avenue — products/semaglutide ↗
- Third Avenue — policies/refund policy ↗
- Third Avenue — official website ↗
- Third Avenue — policies/privacy policy ↗
- Third Avenue — products/tirzepatide ↗
- Third Avenue — pages/glp 1 program ↗
- Third Avenue — glp 1 ↗
- Third Avenue — policies/terms of service ↗